| 1 |
0.9% sodium chloride |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
006 [4] 6 , 14, 51, 53 💬 |
| 2 |
10% intravenous immunoglobulin (ivig) |
Human immunoglobulin G |
- |
- |
- |
014 [1] 14 💬 |
| 3 |
10% liquid formulation of human immunoglobulin |
- |
- |
- |
- |
014 [1] 14 💬 |
| 4 |
: immunoglobulina umana normale 10% per somministrazione endovenosa |
- |
- |
- |
- |
014 [1] 14 💬 |
| 5 |
[clorfenamina maleato] |
Chlorpheniramine |
[4] D00665 D00665, D00668 D00668, D07398 D07398, D07803 D07803 💬 |
HRH1 [1] HRH1 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
014 [1] 14 💬 |
| 6 |
[metilprednisolone sodio succinato] |
- |
- |
- |
- |
014 [1] 14 💬 |
| 7 |
[paracetamolo] |
- |
- |
- |
- |
014 [1] 14 💬 |
| 8 |
[rituximab] |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
014 [1] 14 💬 |
| 9 |
Acthar |
- |
- |
- |
- |
002 [9] 2 , 13, 14, 46, 49, 50, 66, 84, 222 💬 |
| 10 |
Albumin (human) 25%, united states pharmacopeia (usp) |
- |
- |
- |
- |
013 [2] 13, 14 💬 |
| 11 |
Anti-c5 antibody |
- |
- |
- |
- |
011 [4] 11, 14, 62, 109 💬 |
| 12 |
Anti-thymocyte globulin |
- |
- |
- |
- |
011 [18] 11, 13, 14, 36, 40, 41, 42, 45, 46, 49, 51, 60, 62, 65, 164, 283, 284, 285 💬 |
| 13 |
Argx-113 |
- |
- |
- |
- |
011 [4] 11, 14, 35, 63 💬 |
| 14 |
Biological : i10e (human normal immunoglobulin for intravenous administration 100mg/ml) |
Human immunoglobulin G |
- |
- |
- |
014 [1] 14 💬 |
| 15 |
Biological: kiovig® (human normal immunoglobulin for intravenous administration 100mg/ml) |
Human immunoglobulin G |
- |
- |
- |
014 [1] 14 💬 |
| 16 |
Bivv020 |
- |
- |
- |
- |
014 [2] 14, 61 💬 |
| 17 |
Carmustine |
Carmustine |
[1] D00254 D00254 💬 |
- |
- |
011 [5] 11, 13, 14, 28, 60 💬 |
| 18 |
Chloride |
Chloride ion |
- |
- |
- |
006 [25] 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 97, 127, 168, 171, 193, 227, 228, 271, 288, 296, 297, 299 💬 |
| 19 |
Clorfenamina |
Chlorpheniramine |
[4] D00665 D00665, D00668 D00668, D07398 D07398, D07803 D07803 💬 |
HRH1 [1] HRH1 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
014 [1] 14 💬 |
| 20 |
Clorfenamina maleato |
Chlorpheniramine |
[4] D00665 D00665, D00668 D00668, D07398 D07398, D07803 D07803 💬 |
HRH1 [1] HRH1 💬 |
Calcium signaling pathway [3] Calcium signaling pathway, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction |
014 [1] 14 💬 |
| 21 |
Cyclophosphamide |
Cyclophosphamide |
[2] D00287 D00287, D07760 D07760 💬 |
- |
- |
011 [44] 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 85, 93, 96, 162, 164, 172, 222, 224, 256, 265, 274, 283, 284, 285, 288, 326, 331 💬 |
| 22 |
Cytarabine |
Cytarabine |
[3] D00168 D00168, D03046 D03046, D03637 D03637 💬 |
- |
- |
011 [6] 11, 13, 14, 25, 49, 60 💬 |
| 23 |
Device: vital ems+ |
- |
- |
- |
- |
014 [1] 14 💬 |
| 24 |
Dexamethasone |
Dexamethasone |
[9] D00292 D00292, D00975 D00975, D01510 D01510, D01615 D01615, D01632 D01632, D01948 D01948, D02174 D02174, D02591 D02591, D02592 D02592 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [25] 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬 |
| 25 |
Eculizumab |
Eculizumab |
[1] D03940 D03940 💬 |
C5 [1] C5 💬 |
Complement and coagulation cascades [9] Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Staphylococcus aureus infection, Systemic lupus erythematosus |
011 [8] 11, 13, 14, 61, 62, 109, 222, 223 💬 |
| 26 |
Efgartigimod alfa |
Efgartigimod alfa |
[1] D11876 D11876 💬 |
- |
- |
014 [3] 14, 35, 63 💬 |
| 27 |
Efgartigimod ph20 sc |
- |
- |
- |
- |
014 [2] 14, 35 💬 |
| 28 |
Efgartigimod ph20 sc in stage b |
- |
- |
- |
- |
014 [1] 14 💬 |
| 29 |
Etoposide |
Etoposide |
[2] D00125 D00125, D04107 D04107 💬 |
TOP2A [2] TOP2A, TOP2B 💬 |
Platinum drug resistance [1] Platinum drug resistance |
011 [11] 11, 13, 14, 26, 28, 34, 60, 65, 85, 164, 331 💬 |
| 30 |
Fampridine |
Dalfampridine |
[1] D04127 D04127 💬 |
KCNA4 [4] KCNA4, KCNC3, KCND2, KCND3 💬 |
Cortisol synthesis and secretion [4] Cortisol synthesis and secretion, Cushing syndrome, Serotonergic synapse, Spinocerebellar ataxia |
013 [2] 13, 14 💬 |
| 31 |
Fampyra |
- |
- |
- |
- |
013 [2] 13, 14 💬 |
| 32 |
Fibrinogen |
Fibrinogen human |
- |
- |
- |
014 [3] 14, 65, 288 💬 |
| 33 |
Fibrinogen concentrate |
Fibrinogen human |
- |
- |
- |
014 [1] 14 💬 |
| 34 |
Fingolimod |
Fingolimod |
[1] D10001 D10001 💬 |
S1PR1 [1] S1PR1 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [3] 13, 14, 156 💬 |
| 35 |
Fingolimod hydrochloride |
Fingolimod |
[1] D10001 D10001 💬 |
S1PR1 [1] S1PR1 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [2] 13, 14 💬 |
| 36 |
Freeze-dried sulfonated human normal immunoglobulin (ggs) |
Human immunoglobulin G |
- |
- |
- |
014 [3] 14, 43, 45 💬 |
| 37 |
Fty720 |
- |
- |
- |
- |
013 [2] 13, 14 💬 |
| 38 |
Fty720i |
- |
- |
- |
- |
014 [1] 14 💬 |
| 39 |
Gammanorm |
- |
- |
- |
- |
014 [2] 14, 65 💬 |
| 40 |
Gilenya |
- |
- |
- |
- |
002 [3] 2 , 13, 14 💬 |
| 41 |
Gilenya 0,5 mg cápsulas duras |
- |
- |
- |
- |
014 [1] 14 💬 |
| 42 |
H.p. acthar® gel |
- |
- |
- |
- |
014 [1] 14 💬 |
| 43 |
Hematopoietic stem cell transplantation |
- |
- |
- |
- |
011 [12] 11, 13, 14, 19, 20, 35, 46, 49, 51, 96, 234, 285 💬 |
| 44 |
Hidrocloruro de fingolimod |
Fingolimod |
[1] D10001 D10001 💬 |
S1PR1 [1] S1PR1 💬 |
FoxO signaling pathway [3] FoxO signaling pathway, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway |
013 [2] 13, 14 💬 |
| 45 |
Hizentra |
- |
- |
- |
- |
014 [4] 14, 50, 51, 65 💬 |
| 46 |
Hizentra® |
- |
- |
- |
- |
014 [2] 14, 65 💬 |
| 47 |
Human immunoglobulin g |
Human immunoglobulin G |
- |
- |
- |
014 [4] 14, 50, 63, 65 💬 |
| 48 |
Human normal 10% immunoglobulin for intravenous administration |
- |
- |
- |
- |
014 [1] 14 💬 |
| 49 |
Human normal 10% immunoglobulin for intravenous administrationn |
- |
- |
- |
- |
014 [1] 14 💬 |
| 50 |
Human normal immunoglobulin |
Human immunoglobulin G |
- |
- |
- |
011 [9] 11, 13, 14, 43, 45, 50, 51, 63, 65 💬 |
| 51 |
Human normal immunoglobulin (iv) |
Human immunoglobulin G |
- |
- |
- |
011 [4] 11, 14, 63, 65 💬 |
| 52 |
Human normal immunoglobulin (scig) |
Human immunoglobulin G |
- |
- |
- |
014 [1] 14 💬 |
| 53 |
Human normal immunoglobulin for intravenous administration |
Human immunoglobulin G |
- |
- |
- |
014 [3] 14, 51, 65 💬 |
| 54 |
Human normal immunoglobulin g (igg > 98% purity) |
Human immunoglobulin G |
- |
- |
- |
014 [3] 14, 63, 65 💬 |
| 55 |
Hyqvia |
- |
- |
- |
- |
014 [2] 14, 65 💬 |
| 56 |
I10 |
- |
- |
- |
- |
014 [1] 14 💬 |
| 57 |
I10e |
- |
- |
- |
- |
014 [3] 14, 63, 65 💬 |
| 58 |
Igiv, 10% |
- |
- |
- |
- |
014 [2] 14, 65 💬 |
| 59 |
Igpro10 |
- |
- |
- |
- |
014 [3] 14, 51, 65 💬 |
| 60 |
Igpro20 |
- |
- |
- |
- |
014 [4] 14, 50, 51, 65 💬 |
| 61 |
Igpro20 (high dose) |
- |
- |
- |
- |
014 [1] 14 💬 |
| 62 |
Igpro20 (low dose) |
- |
- |
- |
- |
014 [1] 14 💬 |
| 63 |
Igvena*fl 200ml 10g+set |
- |
- |
- |
- |
014 [2] 14, 50 💬 |
| 64 |
Immune globulin |
- |
- |
- |
- |
011 [3] 11, 13, 14 💬 |
| 65 |
Immune globulin 10% intravenous solution |
- |
- |
- |
- |
014 [1] 14 💬 |
| 66 |
Immune globulin intravenous (human), 10% |
- |
- |
- |
- |
014 [2] 14, 65 💬 |
| 67 |
Immune globulin iv (human), 10% caprylate/chromatography purified |
- |
- |
- |
- |
014 [1] 14 💬 |
| 68 |
Immune globulin subcutaneous (human) |
- |
- |
- |
- |
014 [2] 14, 65 💬 |
| 69 |
Immunoglobulin |
- |
- |
- |
- |
013 [3] 13, 14, 63 💬 |
| 70 |
Immunoglobulin g |
- |
- |
- |
- |
011 [7] 11, 13, 14, 49, 50, 63, 65 💬 |
| 71 |
Immunoglobulin perfusion |
- |
- |
- |
- |
014 [1] 14 💬 |
| 72 |
Immunoglobulina umana normale per somministrazione endovenosa |
- |
- |
- |
- |
014 [1] 14 💬 |
| 73 |
Immunoglobuline g |
- |
- |
- |
- |
014 [1] 14 💬 |
| 74 |
Immunoglobulins |
- |
- |
- |
- |
014 [1] 14 💬 |
| 75 |
Immunoglobulins, normal human, for extravascular adm. |
- |
- |
- |
- |
014 [1] 14 💬 |
| 76 |
Immunoglobulins, normal human, for intravascular adm. |
- |
- |
- |
- |
014 [2] 14, 15 💬 |
| 77 |
Intravenous immunoglobulin |
- |
- |
- |
- |
013 [8] 13, 14, 35, 38, 39, 49, 51, 309 💬 |
| 78 |
Intravenous immunoglobulin (ivig) |
Human immunoglobulin G |
- |
- |
- |
014 [4] 14, 17, 164, 296 💬 |
| 79 |
Iqymune |
- |
- |
- |
- |
014 [1] 14 💬 |
| 80 |
Ivig |
Human immunoglobulin G |
- |
- |
- |
011 [8] 11, 13, 14, 17, 35, 50, 51, 65 💬 |
| 81 |
Kiovig |
- |
- |
- |
- |
014 [2] 14, 65 💬 |
| 82 |
Kiovig 100 mg/ml solution for infusion |
- |
- |
- |
- |
014 [2] 14, 65 💬 |
| 83 |
Lipoic acid |
Lipoic acid |
[2] D00048 D00048, D00086 D00086 💬 |
- |
- |
002 [5] 2 , 5 , 13, 14, 20 💬 |
| 84 |
Mabthera |
- |
- |
- |
- |
011 [22] 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271 💬 |
| 85 |
Mabthera - 1 fiala 500 mg 50 ml |
- |
- |
- |
- |
014 [2] 14, 53 💬 |
| 86 |
Md1003 |
- |
- |
- |
- |
002 [5] 2 , 10, 13, 14, 20 💬 |
| 87 |
Melphalan |
Melphalan |
[1] D00369 D00369 💬 |
- |
- |
011 [15] 11, 13, 14, 19, 20, 28, 60, 62, 65, 96, 164, 234, 284, 285, 299 💬 |
| 88 |
Methylprednisolon |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
013 [4] 13, 14, 51, 66 💬 |
| 89 |
Methylprednisolon (solu-medrol) |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
014 [1] 14 💬 |
| 90 |
Methylprednisolone |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [44] 2 , 6 , 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 63, 64, 65, 66, 83, 84, 86, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 |
| 91 |
Methylprednisolone (solu-medrol) |
Methylprednisolone |
[6] D00407 D00407, D00751 D00751, D00979 D00979, D05000 D05000, D05001 D05001, D05002 D05002 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
014 [1] 14 💬 |
| 92 |
Metilprednisolone sodio succinato |
- |
- |
- |
- |
013 [2] 13, 14 💬 |
| 93 |
Newgam |
- |
- |
- |
- |
014 [3] 14, 63, 65 💬 |
| 94 |
Npb-01 |
- |
- |
- |
- |
013 [3] 13, 14, 162 💬 |
| 95 |
Other: fresh frozen plasma |
- |
- |
- |
- |
014 [1] 14 💬 |
| 96 |
Other: laboratory biomarker analysis |
- |
- |
- |
- |
011 [21] 11, 13, 14, 16, 26, 28, 34, 49, 51, 60, 62, 65, 89, 96, 97, 232, 283, 284, 285, 298, 331 💬 |
| 97 |
Panzyga |
- |
- |
- |
- |
014 [1] 14 💬 |
| 98 |
Paracetamolo |
- |
- |
- |
- |
002 [4] 2 , 11, 14, 53 💬 |
| 99 |
Placebo |
- |
- |
- |
- |
003 [26] 3 , 5 , 6 , 13, 14, 37, 40, 46, 49, 50, 51, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 💬 |
| 100 |
Prednisolone |
Prednisolone |
[8] D00472 D00472, D00980 D00980, D00981 D00981, D00982 D00982, D01239 D01239, D01998 D01998, D02156 D02156, D03301 D03301 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
011 [40] 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 |
| 101 |
Prednisone |
Prednisone |
[1] D00473 D00473 💬 |
NR3C1 [1] NR3C1 💬 |
Neuroactive ligand-receptor interaction [1] Neuroactive ligand-receptor interaction |
002 [47] 2 , 6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬 |
| 102 |
Privigen |
- |
- |
- |
- |
011 [4] 11, 14, 51, 65 💬 |
| 103 |
Privigen® |
- |
- |
- |
- |
014 [3] 14, 63, 65 💬 |
| 104 |
Procedure: autologous hematopoietic stem cell transplantation |
- |
- |
- |
- |
011 [6] 11, 13, 14, 28, 49, 51 💬 |
| 105 |
Procedure: peripheral blood stem cell transplantation |
- |
- |
- |
- |
011 [11] 11, 13, 14, 28, 51, 60, 62, 65, 283, 284, 285 💬 |
| 106 |
Procedure: syngeneic bone marrow transplantation |
- |
- |
- |
- |
011 [3] 11, 13, 14 💬 |
| 107 |
Rhuph20 |
- |
- |
- |
- |
013 [2] 13, 14 💬 |
| 108 |
Rituximab |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
011 [47] 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 |
| 109 |
Rituximab (genetical recombination) |
Rituximab |
[1] D02994 D02994 💬 |
MS4A1 [1] MS4A1 💬 |
Hematopoietic cell lineage [1] Hematopoietic cell lineage |
014 [1] 14 💬 |
| 110 |
Rozanolixizumab |
Rozanolixizumab |
- |
- |
- |
011 [3] 11, 14, 63 💬 |
| 111 |
Rvg 51680 |
- |
- |
- |
- |
014 [1] 14 💬 |
| 112 |
Rvg 56083 |
- |
- |
- |
- |
014 [1] 14 💬 |
| 113 |
Sodium chloride |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
006 [20] 6 , 11, 13, 14, 34, 46, 50, 51, 53, 60, 65, 78, 96, 168, 193, 227, 228, 271, 288, 299 💬 |
| 114 |
Sodium chloride 0.9% |
Chloride ion |
[1] D02056 D02056 💬 |
- |
- |
014 [1] 14 💬 |
| 115 |
Soliris |
- |
- |
- |
- |
011 [7] 11, 13, 14, 61, 62, 109, 222 💬 |
| 116 |
Solu medrol - 125 mg/2 ml polvere e solvente per soluzione iniettabile 1 flacone a doppia camera da 125 mg/2 ml |
- |
- |
- |
- |
013 [3] 13, 14, 53 💬 |
| 117 |
Standard of care |
- |
- |
- |
- |
006 [12] 6 , 13, 14, 46, 49, 51, 63, 64, 79, 85, 158, 271 💬 |
| 118 |
Subcutaneous immunoglobulin |
- |
- |
- |
- |
014 [1] 14 💬 |
| 119 |
Subcuvia |
- |
- |
- |
- |
014 [3] 14, 49, 65 💬 |
| 120 |
Tachipirina - 1000 mg compresse 8 compresse |
- |
- |
- |
- |
014 [1] 14 💬 |
| 121 |
Trimeton - 10 mg/1 ml soluzione iniettabile 5 fiale 1 ml |
- |
- |
- |
- |
014 [1] 14 💬 |
| 122 |
Ucb7665 |
- |
- |
- |
- |
011 [3] 11, 14, 63 💬 |
| 123 |
Vivaglobin |
- |
- |
- |
- |
014 [2] 14, 65 💬 |